Homburger advised Molecular Partners AG on the offering. Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin...
Molecular Partners AG’s $20 Million Underwritten Offering of American Depositary Shares
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...